Main menu

Nanopore sequencing enables improvements in Pharmacogenomic CYP2D6 Haplotyping


Long-read single-molecule sequencers, such as those provided by Oxford Nanopore, offer the capability to direct detection and phasing of variants across the CYP2D6 gene. We performed replicate sequencing on the MinION and compared results to the same diagnostic controls on our current MALDI-TOF diagnostic platform (based on 18 SNPs and Indels). Results are highly comparable to current diagnostic genotyping methods (>98.8% concordance), even when downsampled to only 100 reads. While SNP calls were relatively concordant across runs (94%), indels were far less indicating needed future improvements in sequencing, base calling, and/or variant calling. We fully phased all samples into two alleles.

Authors: Ammar Husami

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag